Nicole Eter, EURETINA 2019 – Latest studies in ROP
Nicole Eter (University of Muenster, Germany) talks about the growing prevalence of retinopathy of prematurity and the latest findings of the RAINBOW study, along with an update on OCT-A and how it has changed clinical practice over recent years.
Questions:
1. What are the limitations of the current standard of care for retinopathy of prematurity? (0:04)
2. Could you tell us a little about the RAINBOW study and its findings to date? (1:04)
3. How have the advances in OCT-A changed clinical practice over the past few years? (1:45)
4. Can you tell us about the current research and developments in OCT-A? (2:33)
Support: No funding was received in the production of this video.
